LeukoStrat™ FLT3 Mutation Assay 2.0, ABI

LeukoStrat™ FLT3 Mutation Assay 2.0, ABI
#9-412-0091The LeukoStrat® FLT3 Mutation Assay 2.0 is an in vitro diagnostic product intended for PCR-based detection of FLT3 activating mutations in patients with acute myelogenous leukemia (AML).
This product will only be available until approximately the end of 2022, when it will be replaced by the IVDR version.
- Order number: 9-412-0091
The LeukoStrat® FLT3 Mutation Assay 2.0 is an in vitro diagnostic product intended for PCR-based detection of FLT3 activating mutations in patients with acute myelogenous leukemia (AML). Specifically, the FLT3 Mutation Assay 2.0 can be used to: Identify internal tandem duplications (ITD) in the FLT3 gene Identify tyrosine kinase domain (TKD) mutations in the FLT3 gene
This product will only be available until approximately the end of 2022, when it will be replaced by the IVDR version.
For additional information about the product, please visit the manufacturer's website.
storage temperature: | -70 °C |
shipping method: | dry ice |
regulatory status: | CE-IVD |
detection platform: | ABI |